These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26864638)

  • 1. Natural fatty acid synthase inhibitors as potent therapeutic agents for cancers: A review.
    Zhang JS; Lei JP; Wei GQ; Chen H; Ma CY; Jiang HZ
    Pharm Biol; 2016 Sep; 54(9):1919-25. PubMed ID: 26864638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer drugs targeting fatty acid synthase (FAS).
    Pandey PR; Liu W; Xing F; Fukuda K; Watabe K
    Recent Pat Anticancer Drug Discov; 2012 May; 7(2):185-97. PubMed ID: 22338595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Structures and Bioactivities of Fatty Acid Synthase Inhibitors.
    Jiang H; Gan T; Zhang J; Ma Q; Liang Y; Zhao Y
    Curr Med Chem; 2019; 26(39):7081-7101. PubMed ID: 31538883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.
    Brusselmans K; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Int J Cancer; 2003 Oct; 106(6):856-62. PubMed ID: 12918062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of four plants flavonoids extracts on fatty acid synthase.
    Chen J; Zhuang D; Cai W; Xu L; Li E; Wu Y; Sugiyama K
    J Environ Sci (China); 2009; 21 Suppl 1():S131-4. PubMed ID: 25084411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico screening for identification of fatty acid synthase inhibitors and evaluation of their antiproliferative activity using human cancer cell lines.
    Nisthul A A; Retnakumari AP; A S; Anto RJ; Sadasivan C
    J Recept Signal Transduct Res; 2018 Aug; 38(4):335-341. PubMed ID: 30256698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the development of fatty acid synthase inhibitors as anticancer targets.
    Mullen GE; Yet L
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4363-9. PubMed ID: 26364942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of enantiomeric pairs of 5-(Alk-2-enyl)thiolactomycin and 5-[(E)-Cycloalk-2-enylidenemethyl]thiolactomycin congeners.
    Ohata K; Terashima S
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):920-36. PubMed ID: 19721252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of desoxyrhaponticin and rhaponticin, two natural stilbene glycosides from the Tibetan nutritional food Rheum tanguticum Maxim. ex Balf., on fatty acid synthase and human breast cancer cells.
    Li P; Tian W; Wang X; Ma X
    Food Funct; 2014 Feb; 5(2):251-6. PubMed ID: 24362821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fatty acid synthase: specific target for cancer therapy].
    Li XH; Hou YT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):1-5. PubMed ID: 12518220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells.
    Shiragami R; Murata S; Kosugi C; Tezuka T; Yamazaki M; Hirano A; Yoshimura Y; Suzuki M; Shuto K; Koda K
    Int J Oncol; 2013 Aug; 43(2):431-8. PubMed ID: 23754252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity.
    Brusselmans K; Vrolix R; Verhoeven G; Swinnen JV
    J Biol Chem; 2005 Feb; 280(7):5636-45. PubMed ID: 15533929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH accumulation is responsible for apoptosis in breast cancer cells induced by fatty acid synthase inhibition.
    Cui Y; Xing P; Wang Y; Liu M; Qiu L; Ying G; Li B
    Oncotarget; 2017 May; 8(20):32576-32585. PubMed ID: 28427229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin inhibits intracellular fatty acid synthase and induces apoptosis in human breast cancer MDA-MB-231 cells.
    Fan H; Liang Y; Jiang B; Li X; Xun H; Sun J; He W; Lau HT; Ma X
    Oncol Rep; 2016 May; 35(5):2651-6. PubMed ID: 26985864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid synthase inhibitors: new directions for oncology.
    Kridel SJ; Lowther WT; Pemble CW
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1817-29. PubMed ID: 17970640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.
    Menendez JA; Colomer R; Lupu R
    Oncol Rep; 2004 Aug; 12(2):411-22. PubMed ID: 15254710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells.
    Ho TS; Ho YP; Wong WY; Chi-Ming Chiu L; Wong YS; Eng-Choon Ooi V
    Biomed Pharmacother; 2007 Oct; 61(9):578-87. PubMed ID: 17904792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-UB006: A new fatty acid synthase inhibitor and cytotoxic agent without anorexic side effects.
    Makowski K; Mir JF; Mera P; Ariza X; Asins G; Hegardt FG; Herrero L; García J; Serra D
    Eur J Med Chem; 2017 May; 131():207-221. PubMed ID: 28324785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antagonists of the thioesterase domain of human fatty acid synthase.
    Richardson RD; Smith JW
    Mol Cancer Ther; 2007 Jul; 6(7):2120-6. PubMed ID: 17620441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.